Once you start to lose your hearing, you can’t get it back. But what if you could prevent hearing loss by blocking in advance the effects of loud noises? That’s a route a team of biologists at the University of Iowa and Washington University, St. Louis, says may be possible.
HHF Connects with Researchers at the World’s Largest Conference on Hearing & Balance Science
Nearly 1,800 hearing and balance researchers and related experts gathered Jan. 25–29, 2020, in San Jose, CA for the 43rd annual Midwinter Meeting of the Association for Research in Otolaryngology (ARO), the largest academic association in the field. This included a number of Hearing Health Foundation (HHF)-affiliated researchers, members of the HHF Board of Directors and scientific advisory bodies, and HHF staff.
Changes in the Tiny Vessels of the Inner Ear’s Balance Organ Reveal Links to Ménière’s Disease
By Gail Ishiyama, M.D.
The integrity and permeability of the blood labyrinthine barrier (BLB) in the inner ear is important to maintain an adequate blood supply and to control the passage of fluids, molecules, and ions. Identifying the cellular and structural components of the BLB is critical to understanding inner ear microvasculature (micro vessels) and designing the efficient delivery of therapeutics across the BLB, potentially to treat hearing and balance disorders such as Ménière’s disease.
(A) Uniformly thick vessels (red) in a vestibular schwannoma utricle with arrows pointing to a wrapping pericyte cell. (B) In a thick vessel from a Ménière’s patient, there is disorganization of the pericyte processes (white arrows) and evidence of degeneration of the vascular endothelial cells and thin areas of the vessel wall (green). (C) This zoomed-out image shows constriction in the blood vessels (left arrow).
My team and I used fluorescence microscopy to study the microvasculature in the utricular macula, which detects the body’s linear movement, of patients who had undergone surgery for Ménière’s disease or vestibular schwannoma. As published in Frontiers in Cellular Neuroscience on Oct. 4, 2019, we found a significantly decreased number of junctions, total vessel length, and average vessel length in the microvasculature in Ménière’s disease specimens compared with vestibular schwannoma and control specimens.
The vessels in Ménière’s specimens appeared disorganized with abnormal, uneven, or constricted shapes, atypical branching, and decreased coverage and thinning, leaving vascular endothelial cells (VECs) exposed and unprotected. Our prior research had shown that in Ménière’s disease, VECs are damaged and that they contain oxidative stress markers. Our new study underscores possible mechanisms behind BLB disruption in Ménière’s and the subsequent signs of edema (excess fluid), which disrupts the homeostasis of the hearing and balance structures.
The report indicates that interventions aimed at preventing damage to the microvasculature may help stop the progression of damage to the vestibular system, restoring balance and preventing vertigo spells. It could be that decreasing vessel constriction and BLB leakage will help prevent chronic damage to balance structures; this may help explain how steroids administered to Ménière’s patients provide temporary relief from dizziness symptoms.
The paper also shows that human inner ear tissue can be used to compare and contrast findings in animal models to design better therapies for vestibular and auditory disorders. We hope that the deeper understanding of the anatomy of the BLB and its changes during disease will enable the development of noninvasive delivery strategies for treating hearing and balance disorders.
Gail Ishiyama, M.D., a 2016 and 2018 Emerging Research Grants recipient, is a clinician-scientist who is a neurology associate professor at UCLA’s David Geffen School of Medicine.
You can make a donation to support the top-tier scientists funded by Hearing Health Foundation (HHF). With stellar charity ratings from all watchdogs, HHF pledges to use your gift wisely.
The Latest Research on Hair Cell Regeneration to Restore Hearing
The New York Academy of Sciences (NYAS) hosted “Hearing Restoration and Hair Cell Regeneration” to connect internationally recognized hearing loss experts from academia, industry, government, and nonprofit organizations. Hearing Health Foundation (HHF) scientists spoke and presented.
ERG Applications Open Monday, October 14
Hearing Health Foundation (HHF)’s next Emerging Research Grants (ERG) grant cycle is approaching its start. HHF is especially pleased to announce a significant increase in funding available for our future ERG grantees.
In Memoriam: Robert Dobie, M.D.
Hearing Health Foundation (HHF) is deeply saddened to report that Council of Scientific Trustees (CST) member and Senior Scientific Trustee Robert Dobie, M.D. (Bob), passed away on September 4, 2019.
Our Impact Invigorated: HHF Visits the NIDCD
In my role as CEO of Hearing Health Foundation (HHF), most of my time is spent liaising with the individuals who make our groundbreaking work possible from our New York City office. I was fortunate to recently step away from my typical routine to witness the excitement of hearing and balance science at the National Institutes of Health (NIH).
A Newly Identified Neuron in a Brain Region Tied to Hearing
My lab at the University of Michigan identified a novel neuron type called VIP neurons. VIP neurons make a small protein called vasoactive intestinal peptide. Despite its name, previous studies have shown that VIP is made by specific types of neurons in several other brain regions.
Lasting Effects From Head and Brain Injury
In our research “Patient‐Reported Auditory Handicap Measures Following Mild Traumatic Brain Injury,” published in The Laryngoscope, we examined auditory complaints following traumatic brain injury, as well as changes that occur to the peripheral vestibular system in the postmortem setting.
Making Sense of Sound
Valeriy Shafiro conducts research in hearing and speech perception that focuses on finding new ways to diagnose auditory deficits and improve communication abilities in adults.